Casdin Capital’s UnitedHealth UNH Stock Holding History

Casdin Capital’s Portfolio UNH Stock Details UNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-50,000	Closed	-$16.5M	–	47
2025 Q4	$16.5M	Buy	50,000 +25,000	+100%	+$8.47M	1.03%	18
2025 Q3	$8.63M	Buy	+25,000	New	+$7.56M	0.72%	20

Other funds holding UNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Casdin Capital's UNH Position: Q1 2026 in Review

Casdin Capital sold out of UnitedHealth (UNH) in Q1 2026, closing a stake of 50,000 shares — an estimated $16.5M sold.

Casdin Capital first reported a position in UNH in Q3 2025 and held it in 2 quarters. The position peaked at $16.5M in Q4 2025. 3,024 funds tracked by Wall St. Rank hold UNH as of Q1 2026.

Casdin Capital reported no remaining UnitedHealth position as of Q1 2026 after selling out during the quarter.
Casdin Capital sold 50,000 UnitedHealth shares in Q1 2026, an estimated $16.5M.
Casdin Capital first reported a position in UnitedHealth in Q3 2025 and held it in 2 quarters.
Casdin Capital's UnitedHealth position peaked at $16.5M in Q4 2025.
3,024 funds tracked by Wall St. Rank held UnitedHealth as of Q1 2026.

Based on Casdin Capital's 13F filing for Q1 2026, filed 15 May 2026.